company background image
5G3 logo

TalkMed Group SGX:5G3 Stock Report

Last Price

S$0.42

Market Cap

S$557.2m

7D

6.3%

1Y

2.4%

Updated

15 Jul, 2024

Data

Company Financials

5G3 Stock Overview

An investment holding company, provides medical oncology, stem cell transplants, palliative care, and other related services in Singapore, China, Hong Kong, Vietnam, India, New Zealand, Australia, and the United States.

5G3 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends3/6

TalkMed Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for TalkMed Group
Historical stock prices
Current Share PriceS$0.42
52 Week HighS$0.46
52 Week LowS$0.35
Beta0.20
11 Month Change5.00%
3 Month Change2.44%
1 Year Change2.44%
33 Year Change3.70%
5 Year Change-15.15%
Change since IPO2.44%

Recent News & Updates

Unpleasant Surprises Could Be In Store For TalkMed Group Limited's (SGX:5G3) Shares

Apr 08
Unpleasant Surprises Could Be In Store For TalkMed Group Limited's (SGX:5G3) Shares

Recent updates

Unpleasant Surprises Could Be In Store For TalkMed Group Limited's (SGX:5G3) Shares

Apr 08
Unpleasant Surprises Could Be In Store For TalkMed Group Limited's (SGX:5G3) Shares

TalkMed Group's (SGX:5G3) Solid Earnings Have Been Accounted For Conservatively

Mar 01
TalkMed Group's (SGX:5G3) Solid Earnings Have Been Accounted For Conservatively

Shareholder Returns

5G3SG HealthcareSG Market
7D6.3%2.7%2.5%
1Y2.4%-19.2%2.2%

Return vs Industry: 5G3 exceeded the SG Healthcare industry which returned -19.2% over the past year.

Return vs Market: 5G3 matched the SG Market which returned 2.2% over the past year.

Price Volatility

Is 5G3's price volatile compared to industry and market?
5G3 volatility
5G3 Average Weekly Movement4.4%
Healthcare Industry Average Movement4.9%
Market Average Movement4.7%
10% most volatile stocks in SG Market13.2%
10% least volatile stocks in SG Market2.1%

Stable Share Price: 5G3 has not had significant price volatility in the past 3 months.

Volatility Over Time: 5G3's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997232Peng Tiam Angwww.talkmed.com.sg

TalkMed Group Limited, an investment holding company, provides medical oncology, stem cell transplants, palliative care, and other related services in Singapore, China, Hong Kong, Vietnam, India, New Zealand, Australia, and the United States. It operates through two segments: Oncology Services; and Cellular and Gene Therapy Related Products and Services. The company offers medical oncology services in the areas of breast, colon, lung, liver, biliary and pancreatic, gastro-intestinal, head and neck, genitourinary and gynaecological, and haematology malignancies and brain cancers, as well as lymphoma and leukaemia.

TalkMed Group Limited Fundamentals Summary

How do TalkMed Group's earnings and revenue compare to its market cap?
5G3 fundamental statistics
Market capS$557.20m
Earnings (TTM)S$32.18m
Revenue (TTM)S$83.79m

17.3x

P/E Ratio

6.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
5G3 income statement (TTM)
RevenueS$83.79m
Cost of RevenueS$33.78m
Gross ProfitS$50.01m
Other ExpensesS$17.84m
EarningsS$32.18m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.024
Gross Margin59.69%
Net Profit Margin38.40%
Debt/Equity Ratio5.0%

How did 5G3 perform over the long term?

See historical performance and comparison

Dividends

5.2%

Current Dividend Yield

91%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.